Literature DB >> 28956098

How to Size ASDs for Percutaneous Closure.

Isabelle Boon1, Katrien Vertongen1, Bernard P Paelinck2, Laurent Demulier3, An Van Berendoncks4, Catherine De Maeyer4, Fabienne Marchau5, Joseph Panzer6, Kristof Vandekerckhove6, Daniel De Wolf7.   

Abstract

Percutaneous closure is the treatment of choice for secundum-type atrial septal defects (ASD). Balloon sizing (BS) has been the method of choice for deciding on device size. Improved 2D- and 3D-transesophageal echocardiographic (TEE) imaging challenged the necessity of BS. Balloon sizing was performed with two additional techniques to measure the stretched dimension of the ASD. The 1st method uses a stiff guide wire which stretches the ASD and 2D TEE. The second technique uses 3D TEE. Two hundred and thirty-six patients with minimum 1-year follow-up were enrolled. The population was classified into three groups: BS (group 1) n = 90, 2D-TEE (group 2) n = 87, and 3D-TEE (group 3) n = 59. All groups showed a distinct correlation between the maximum baseline dimensions and the device size (R = 0.821). The relative expansion rate did not differ between BS and 3D-TEE. Group 2 (2D-TEE) showed a significantly lower expansion rate. Procedural success and complications did not differ statistically between the 3 groups. 2D TEE sizing was the simplest method without loss of accuracy. 3D sizing offers the advantage of accurate and fast shape assessment, but resulted in more undersizing. Accurate sizing of ASDs with a floppy septum remains a challenge.

Entities:  

Keywords:  ASD; Device; Echocardiography; Percutaneous closure; Sizing; Three dimensional

Mesh:

Year:  2017        PMID: 28956098     DOI: 10.1007/s00246-017-1743-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  27 in total

1.  Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications.

Authors:  Stefan H Ostermayer; Shubhika Srivastava; John T Doucette; H Helen Ko; Miwa Geiger; Ira A Parness; Barry A Love
Journal:  Catheter Cardiovasc Interv       Date:  2015-09-01       Impact factor: 2.692

2.  Assessment of atrial septal defect size with 3D-transesophageal echocardiography: comparison with balloon method.

Authors:  Tony Abdel-Massih; Yves Dulac; Assaad Taktak; Yacine Aggoun; Pierre Massabuau; Meyer Elbaz; Didier Carrié; Philippe Acar
Journal:  Echocardiography       Date:  2005-02       Impact factor: 1.724

3.  Sizing balloon-induced tear of the atrial septum.

Authors:  S Harikrishnan; Namboodiri K K Narayanan; Sivasankaran Sivasubramonian
Journal:  J Invasive Cardiol       Date:  2005-10       Impact factor: 2.022

4.  Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these changes while using transesophageal echocardiography or intracardiac echocardiography?

Authors:  Kiran Mallula; Zahid Amin
Journal:  Pediatr Cardiol       Date:  2012-05-11       Impact factor: 1.655

5.  Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.

Authors:  Supaporn Roymanee; Worakan Promphan; Nakharin Tonklang; Kanjarut Wongwaitaweewong
Journal:  Pediatr Cardiol       Date:  2015-01-30       Impact factor: 1.655

6.  Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.

Authors:  François Godart; Ali Houeijeh; Morgan Recher; Charles Francart; Anne-Sophie Polge; Marjorie Richardson; Marie-Andrée Cajot; Alain Duhamel
Journal:  Arch Cardiovasc Dis       Date:  2014-11-11       Impact factor: 2.340

7.  Measurement of atrial septal defect during cardiac catheterization. Experimental and clinical results.

Authors:  T D King; S L Thompson; N L Mills
Journal:  Am J Cardiol       Date:  1978-03       Impact factor: 2.778

8.  Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series.

Authors:  Nikolaus A Haas; Dagmar B Soetemann; Ismail Ates; Osman Baspinar; Igor Ditkivskyy; Christopher Duke; Francois Godart; Avraham Lorber; Edmundo Oliveira; Eustaquio Onorato; Feyza Pac; Worakan Promphan; Frank-Thomas Riede; Supaporn Roymanee; Robert Sabiniewicz; Suhair Omar Shebani; Horst Sievert; Do Tin; Christoph M Happel
Journal:  Catheter Cardiovasc Interv       Date:  2016-03-31       Impact factor: 2.692

Review 9.  Transcatheter closure of secundum atrial septal defects.

Authors:  Suhaib Kazmouz; Damien Kenny; Qi-Ling Cao; Clifford J Kavinsky; Ziyad M Hijazi
Journal:  J Invasive Cardiol       Date:  2013-05       Impact factor: 2.022

10.  Trans-catheter closure of atrial septal defect: Balloon sizing or no Balloon sizing - single centre experience.

Authors:  Saurabh Kumar Gupta; S Sivasankaran; S Bijulal; Jagan Mohan Tharakan; S Harikrishnan; Kvk Ajit
Journal:  Ann Pediatr Cardiol       Date:  2011-01
View more
  3 in total

1.  Assessment of atrial septal defect using 2D or real-time 3D transesophageal echocardiography and outcomes following transcatheter closure.

Authors:  Bingqing Deng; Kequan Chen; Tucheng Huang; Yulin Wei; Yingmei Liu; Li Yang; Qiong Qiu; Shaoxin Zheng; Hanlu Lv; Peiwei Wang; Ruqiong Nie; Jingfeng Wang
Journal:  Ann Transl Med       Date:  2021-08

2.  German Registry for Cardiac Operations and Interventions in Patients with Congenital Heart Disease: Report 2021 and 9 Years' Longitudinal Observations on Fallot and Coarctation Patients.

Authors:  Sven Dittrich; Claudia Arenz; Otto Krogmann; Anja Tengler; Renate Meyer; Ulrike Bauer; Michael Hofbeck; Andreas Beckmann; Alexander Horke
Journal:  Thorac Cardiovasc Surg       Date:  2022-09-29       Impact factor: 1.756

3.  Transcatheter closure of a residual shunt with posteroinferior deficient rim after surgical closure of an ASD: a case report.

Authors:  Xicheng Deng; Taoyue Yao; Yefeng Wang; Guangxian Yang; Wenjuan Chen; Peng Huang; Zhi Chen
Journal:  BMC Cardiovasc Disord       Date:  2020-07-22       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.